Bisphosphonates in the treatment of osteoporosisPOOLE, Kenneth E; COMPSTON, Juliet E.BMJ (Overseas and retired doctors ed.). 2012, Vol 345, Num 7869, pp 44-47, issn 1759-2151, 4 p.Article

Bisphosphonate Remains Highly Localized After Elution From Porous Implants : Hip Society Meetings 2010MCKENZIE, Kimberly; BOBYN, J. Dennis; ROBERTS, Jacintha et al.Clinical orthopaedics and related research. 2011, Vol 469, Num 2, pp 514-522, issn 0009-921X, 9 p.Article

Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesisREUBEN, Jayne S; DINH, Laura; LEE, Jane et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2011, Vol 111, Num 2, pp 196-204, issn 1079-2104, 9 p.Article

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the MandibleMORRIS, Patrick G; HUDIS, Clifford; CARRASQUILLO, Jorge et al.Journal of oral and maxillofacial surgery. 2011, Vol 69, Num 1, pp 114-119, issn 0278-2391, 6 p.Article

Une ostéonécrose de la mâchoire = Osteonecrosis of the jawPIERROT-DESEILLIGNY DESPUJOL, C; POUCHOT, J.La Revue de médecine interne (Paris). 2009, Vol 30, Num 8, pp 706-707, issn 0248-8663, 2 p.Article

Bisphosphonates―Role in Cancer TherapiesMEHROTRA, Bhoomi.Journal of oral and maxillofacial surgery. 2009, Vol 67, Num 5, pp 19-26, issn 0278-2391, 8 p., SUP1Article

Bisphosphonates for post-menopausal osteoporosis: are they all the same?RIZZOLI, R.QJM (Oxford. 1994. Print). 2011, Vol 104, Num 4, pp 281-300, issn 1460-2725, 20 p.Article

Alternative Indications for Bisphosphonate TherapyLANDESBERG, Regina; EISIG, Sidney; FENNOY, Ilene et al.Journal of oral and maxillofacial surgery. 2009, Vol 67, Num 5, pp 27-34, issn 0278-2391, 8 p., SUP1Article

Bisphosphonates : Mechanism of Action and Role in Clinical PracticeDRAKE, Matthew T; CLARKE, Bart L; KHOSLA, Sundeep et al.Mayo Clinic proceedings. 2008, Vol 83, Num 9, pp 1032-1045, issn 0025-6196, 14 p.Article

The effect of alendronate on progression of spinal osteophytes and disc-space narrowingNEOGI, T; NEVITT, M. C; ENSRUD, K. E et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 10, pp 1427-1430, issn 0003-4967, 4 p.Article

Neglected Population of Patients Receiving Intravenous BisphosphonatesANNIBALI, Susanna; BIGNOZZI, Isabella; OTTOLENGHI, Livia et al.Journal of oral and maxillofacial surgery. 2012, Vol 70, Num 9, pp 2097-2098, issn 0278-2391, 2 p.Article

The Effect of Soaking Allograft in Bisphosphonate: A Pilot Dose-response StudyJAKOBSEN, Thomas; BAAS, Jørgen; BECHTOLD, Joan E et al.Clinical orthopaedics and related research. 2010, Vol 468, Num 3, pp 867-874, issn 0009-921X, 8 p.Article

Osteoporose und Bisphosphonate = Osteoporosis and bisphosphonateZUBER, M. A.Zeitschrift für Rheumatologie (Print). 2007, Vol 66, Num 8, pp 713-715, issn 0340-1855, 3 p.Article

Bisphosphonates intraveineux pour la prévention de l'ostéoporose cortico-induiteDUBOC, Henri.La Lettre de l'hépato-gastroentérologue. 2007, Vol 10, Num 9, pp 6-6, issn 1286-580X, 1 p., SUP2Article

Locally Delivered Bisphosphonate for Enhancement of Bone Formation and Implant FixationBOBYN, J. Dennis; MCKENZIE, Kimberly; KARABASZ, Dorota et al.Journal of bone and joint surgery. American volume (Print ed.). 2009, Vol 91A, pp 23-31, issn 0021-9355, 9 p., SUP6Conference Paper

Les bisphosphonates dans l'ostéoporose cortico-induite: efficacité et toléranceLESPESSAILLES, Eric.Revue du rhumatisme (Ed. française). 2013, Vol 80, Num 2, pp 123-129, issn 1169-8330, 7 p.Article

Bisphosphonate-Related Osteonecrosis of the Mandible Secondary to Postural PressureYANKOVA, Zhenya; GANESAN, Kandasamy; SHAH, Ketan et al.Journal of oral and maxillofacial surgery. 2012, Vol 70, Num 7, pp 1584-1586, issn 0278-2391, 3 p.Article

Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viabilityBELLIDO, Teresita; PLOTKIN, Lilian I.Bone (New York, NY). 2011, Vol 49, Num 1, pp 50-55, issn 8756-3282, 6 p.Article

Inhibition of Necrotic Actions of Nitrogen-Containing Bisphosphonates (NBPs) and Their Elimination From Bone by Etidronate (a Non-NBP): A Proposal for Possible Utilization of Etidronate as a Substitution Drug for NBPsOIZUMI, Takefumi; FUNAYAMA, Hiromi; SUGAWARA, Shunji et al.Journal of oral and maxillofacial surgery. 2010, Vol 68, Num 5, pp 1043-1054, issn 0278-2391, 12 p.Article

Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective studySCOLETTA, Matteo; ARDUINO, Paolo G; DALMASSO, Paola et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010, Vol 110, Num 1, pp 46-53, issn 1079-2104, 8 p.Article

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial dataBELL, Katy J. L; HAYEN, Andrew; MACASKILL, Petra et al.BMJ. British medical journal (International ed.). 2009, Vol 338, Num 7710, issn 0959-8146, p. 1553Article

Ostéonécrose de la machoire sous biphosphonates : aspects radiologiques = Osteonecrosis of the jaw and biphosphonates : Imaging featuresORLANDINI, F; BOSSARD, D; BLANC, G et al.Journal de radiologie (Paris). 2009, Vol 90, Num 2, pp 199-205, issn 0221-0363, 7 p.Article

Safety of Bisphosphonates in the Treatment of OsteoporosisRECKER, Robert R; LEWIECKI, E. Michael; MILLER, Paul D et al.The American journal of medicine. 2009, Vol 122, Num 2A, issn 0002-9343, S22-S32, SUPArticle

Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Initial Discovery and Subsequent DevelopmentRUGGIERO, Salvatore L.Journal of oral and maxillofacial surgery. 2009, Vol 67, Num 5, pp 13-18, issn 0278-2391, 6 p., SUP1Article

Ostéonécrose de la mâchoire associée à un traitement par bisphosphonates : extraits du rapport de la task force de l'ASBMR et recommandations françaisesTHOMAS, T.La Lettre du rhumatologue. 2008, Num 339, pp 13-14, issn 0761-5027, 2 p.Article